Systematic analysis of randomised controlled trials of Chinese herb medicine for non-alcoholic steatohepatitis (NASH): implications for future drug development and trial design

BACKGROUND: Non-alcoholic steatohepatitis (NASH) is a liver disease currently lacking an approved therapy, resulting in significant clinical demand. Traditional Chinese medicines (TCMs) have been commonly used to manage NASH. This study aimed to systematically analyse the randomised controlled trial...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Xianwen, Shi, Junnan, Lai, Yunfeng, Xue, Yan, Ung, Carolina Oi Lam, Hu, Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10199512/
https://www.ncbi.nlm.nih.gov/pubmed/37208742
http://dx.doi.org/10.1186/s13020-023-00761-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10199512/
https://www.ncbi.nlm.nih.gov/pubmed/37208742
http://dx.doi.org/10.1186/s13020-023-00761-5

Ejemplares similares